| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |